Aura Biosciences, Inc.AURANASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+168.2%
5Y CAGR+138.7%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+168.2%/yr
Annual compound
5Y CAGR
+138.7%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
77.5x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20240.12+42.6%
20230.09-18.8%
20220.11+1566.0%
20210.01+726.3%
20200.00-51.4%
20190.00-